INTERVIEW | Plasma therapy should be explored in 2nd Covid wave too, says immunologist Dr Dipyaman Ganguly
By Sumi Sukanya Dutta
Express News Service
Q: So far, what have we understood about our immune response to the SARS CoV 2, and what remains to be understood?
A: We could gather quite a bit of information from the earlier stints of the pandemic in 2020. But I must say the disease caused by the coronavirus is too enigmatic to be confident that we know everything about it by now. The most important lacunae are how the new variants will affect the course of the pandemic.